Medicine
Ciprofloxacin 3 mg/mL eye drops
Ciprofloxacin 3 mg/mL eye drops is a generic prescription medicine for ophthalmic use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 2° to 25°C (36° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Ciprofloxacin
- Brand
- Sold under the generic name
- Strength
- 3 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle, 10 mL, 5 mL and 14 more
- Manufacturers
- AsclemedNuCare Pharmaceuticals,IncSandozA-S Medication SolutionsProficient RxRedpharm DrugPreferred PharmaceuticalsRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Store at 2° to 25°C (36° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01MA02 Ciprofloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 May 2004
- Identifiers
- RxCUI 309307DailyMed set ID ab52b14d-345b-47ff-a832-465caddd3801, 5cf0f572-48fc-6a3a-e053-2991aa0a8437, 78641acd-eedf-4b68-bb18-da0874415f59 +8NDC 61314-656, 68071-4139, 68788-8198 +8Application NDA019992
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 61314-656-05 | Sandoz | 7 May 2004 |
| 1 bottle, plastic in 1 carton / 10 mL in 1 bottle, plastic | 61314-656-10 | Sandoz | 7 May 2004 |
| 1 bottle, plastic in 1 carton / 2.5 mL in 1 bottle, plastic | 61314-656-25 | Sandoz | 7 May 2004 |
| 10 mL in 1 box | 68071-3351-3 | NuCare Pharmaceuticals,Inc | 20 July 2017 |
| 5 mL in 1 box | 68071-4139-5 | NuCare Pharmaceuticals,Inc | 1 November 2017 |
| 2.5 mL in 1 box | 68071-4235-3 | NuCare Pharmaceuticals,Inc | 17 January 2018 |
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 50090-0882-0 | A-S Medication Solutions | 28 November 2014 |
| 1 bottle, plastic in 1 carton / 2.5 mL in 1 bottle, plastic | 50090-1754-0 | A-S Medication Solutions | 20 March 2015 |
| 1 bottle, plastic in 1 carton / 2.5 mL in 1 bottle, plastic | 76420-942-03 | Asclemed | 29 March 2025 |
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 76420-942-05 | Asclemed | 29 March 2025 |
| 1 bottle, plastic in 1 carton / 10 mL in 1 bottle, plastic | 76420-942-10 | Asclemed | 29 March 2025 |
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 68788-8198-5 | Preferred Pharmaceuticals | 23 May 2022 |
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 63187-985-05 | Proficient Rx | 1 March 2018 |
| 1 bottle, plastic in 1 carton / 10 mL in 1 bottle, plastic | 63187-985-10 | Proficient Rx | 1 December 2018 |
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 67296-0142-1 | Redpharm Drug | 7 May 2004 |
| 2 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 67296-0142-2 | Redpharm Drug | 7 May 2004 |
| 1 bottle, plastic in 1 carton / 5 mL in 1 bottle, plastic | 70518-1170-0 | Remedyrepack | 15 May 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 October 1987 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ciprofloxacin
Clinical summary
Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated, among other approved uses. MedsAcross supplies Ciprofloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CiprofloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cipro prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ciprofloxacin 3 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.